Skip to main content
Erschienen in: American Journal of Clinical Dermatology 3/2009

01.06.2009 | Review Article

The Asian Dermatologic Patient

Review of Common Pigmentary Disorders and Cutaneous Diseases

verfasst von: Stephanie G.Y. Ho, Dr Henry H.L. Chan

Erschienen in: American Journal of Clinical Dermatology | Ausgabe 3/2009

Einloggen, um Zugang zu erhalten

Abstract

The Asian patient with Fitzpatrick skin types III–V is rarely highlighted in publications on cutaneous disorders or cutaneous laser surgery. However, with changing demographics, Asians will become an increasingly important group in this context. Although high melanin content confers better photoprotection, photodamage in the form of pigmentary disorders is common. Melasma, freckles, and lentigines are the epidermal disorders commonly seen, whilst nevus of Ota and acquired bilateral nevus of Ota-like macules are common dermal pigmentary disorders. Post-inflammatory hyperpigmentation (PIH) occurring after cutaneous injury remains a hallmark of skin of color. With increasing use of lasers and light sources in Asians, prevention and management of PIH is of great research interest. Bleaching agents, chemical peels, intense pulsed light (IPL) treatments, and fractional skin resurfacing have all been used with some success for the management of melasma. Q-switched (QS) lasers are effective for the management of epidermal pigmentation but are associated with a high risk of PIH. Long-pulsed neodymium-doped yttrium aluminum garnet (Nd:YAG) lasers and IPL sources pose less of a PIH risk but require a greater number of treatment sessions. Dermal pigmentary disorders are better targeted by QS ruby, QS alexandrite, and QS 1064-nm Nd:YAG lasers, but hyper- and hypopigmentation may occur. Non-ablative skin rejuvenation using a combination approach with different lasers and light sources in conjunction with cooling devices allows different skin chromophores to be targeted and optimal results to be achieved, even in skin of color. Deep-tissue heating using radiofrequency and infra-red light sources affects the deep dermis and achieves enhanced skin tightening, resulting in eyebrow elevation, rhytide reduction, and contouring of the lower face and jawline. For management of severe degrees of photoaging, fractional resurfacing is useful for wrinkle and pigment reduction, as well as acne scarring.
Acne, which is common in Asians, can be treated with topical and oral antibacterials, hormonal treatments, and isotretinoin. Infra-red diode lasers used with a low-fluence, multiple-pass approach have also been shown to be effective with few complications. Fractional skin resurfacing is very useful for improving the appearance of acne scarring. Hypertrophic and keloid scarring, another common condition seen in Asians, can be treated with the combined used of intralesional triamcinolone and fluorouracil, followed by pulsed-dye laser. Esthetic enhancement procedures such as botulinum toxin type A and fillers are becoming increasingly popular. These are effective for rhytide improvement and facial or body contouring. We highlight the differences between Asian skin and other skin types and review conditions common in skin of color together with treatment strategies.
Literatur
2.
Zurück zum Zitat US Census Bureau, US Department of Commerce. US Census 2000. Washington, DC: US Census Bureau, Public Information Office, 2001 Sep US Census Bureau, US Department of Commerce. US Census 2000. Washington, DC: US Census Bureau, Public Information Office, 2001 Sep
3.
Zurück zum Zitat US Census Bureau News. Census bureau projects tripling of Hispanic and Asian populations in 50 years; non-Hispanic Whites may drop to half of total population. Washington, DC: Bureau of International Information Programs, U.S. Department of State, 2004 Mar 18 US Census Bureau News. Census bureau projects tripling of Hispanic and Asian populations in 50 years; non-Hispanic Whites may drop to half of total population. Washington, DC: Bureau of International Information Programs, U.S. Department of State, 2004 Mar 18
4.
Zurück zum Zitat Chan HHL, Jackson B. Laser treatment on ethnic skin. In: Lim HW, Honigsmann H, Hawk JLM, editors. Photodermatology. New York: Informa Healthcare, 2007: 417–32 Chan HHL, Jackson B. Laser treatment on ethnic skin. In: Lim HW, Honigsmann H, Hawk JLM, editors. Photodermatology. New York: Informa Healthcare, 2007: 417–32
5.
Zurück zum Zitat Szabo G. Pigment cell biology. In: Gordon M, editor. Mitochondria and other cytoplasmic inclusions. New York: Academic Press, 1959 Szabo G. Pigment cell biology. In: Gordon M, editor. Mitochondria and other cytoplasmic inclusions. New York: Academic Press, 1959
6.
Zurück zum Zitat Kaidbey KH, Agin PP, Sayre RM, et al. Photoprotection by melanin: a comparison of black and Caucasian skin. J Am Acad Dermatol 1979; 1: 249–60PubMedCrossRef Kaidbey KH, Agin PP, Sayre RM, et al. Photoprotection by melanin: a comparison of black and Caucasian skin. J Am Acad Dermatol 1979; 1: 249–60PubMedCrossRef
7.
Zurück zum Zitat Tadokoro T, Kobayashi N, Zmudzka BZ, et al. UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin and photosensitivity. FASEB J 2003; 17: 1177–9PubMed Tadokoro T, Kobayashi N, Zmudzka BZ, et al. UV-induced DNA damage and melanin content in human skin differing in racial/ethnic origin and photosensitivity. FASEB J 2003; 17: 1177–9PubMed
8.
Zurück zum Zitat Kotrajaras R, Kligman AM. The effect of topical tretinoin on photodamaged facial skin: the Thai experience. Br J Dermatol 1993; 129: 302–9PubMedCrossRef Kotrajaras R, Kligman AM. The effect of topical tretinoin on photodamaged facial skin: the Thai experience. Br J Dermatol 1993; 129: 302–9PubMedCrossRef
9.
Zurück zum Zitat Griffiths CEM, Wang TS, Hamilton TA, et al. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol 1992; 128: 347–51PubMedCrossRef Griffiths CEM, Wang TS, Hamilton TA, et al. A photonumeric scale for the assessment of cutaneous photodamage. Arch Dermatol 1992; 128: 347–51PubMedCrossRef
10.
Zurück zum Zitat Larnier C, Ortonne JP, Venot A, et al. Evaluation of cutaneous photodamage using a photographic scale. Br J Dermatol 1994; 130: 167–73PubMedCrossRef Larnier C, Ortonne JP, Venot A, et al. Evaluation of cutaneous photodamage using a photographic scale. Br J Dermatol 1994; 130: 167–73PubMedCrossRef
11.
12.
Zurück zum Zitat Goh SH. The treatment of visible signs of senescence: the Asian experience. Br J Dermatol 1990; 122 Suppl. 35: 105–9PubMedCrossRef Goh SH. The treatment of visible signs of senescence: the Asian experience. Br J Dermatol 1990; 122 Suppl. 35: 105–9PubMedCrossRef
13.
Zurück zum Zitat Chan HHL, Manstein D, Yu CS, et al. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med 2007; 39: 381–5PubMedCrossRef Chan HHL, Manstein D, Yu CS, et al. The prevalence and risk factors of post-inflammatory hyperpigmentation after fractional resurfacing in Asians. Lasers Surg Med 2007; 39: 381–5PubMedCrossRef
14.
Zurück zum Zitat Chan HHL. Effective and safe use of lasers, light sources, and radiofrequency devices in the clinical management of Asian patients with selected dermatoses. Lasers Surg Med 2005; 37: 179–85PubMedCrossRef Chan HHL. Effective and safe use of lasers, light sources, and radiofrequency devices in the clinical management of Asian patients with selected dermatoses. Lasers Surg Med 2005; 37: 179–85PubMedCrossRef
15.
Zurück zum Zitat Grimes PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453–7PubMedCrossRef Grimes PE. Melasma: etiologic and therapeutic considerations. Arch Dermatol 1995; 131: 1453–7PubMedCrossRef
16.
Zurück zum Zitat Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002; 146: 228–37PubMedCrossRef Kang WH, Yoon KH, Lee ES, et al. Melasma: histopathological characteristics in 56 Korean patients. Br J Dermatol 2002; 146: 228–37PubMedCrossRef
17.
Zurück zum Zitat Grekin RC, Shelton RM, Geisse JK, et al. 510nm pigmented lesion dye laser: its characteristics and clinical uses. J Dermatol Surg Oncol 1993; 19: 380–7PubMed Grekin RC, Shelton RM, Geisse JK, et al. 510nm pigmented lesion dye laser: its characteristics and clinical uses. J Dermatol Surg Oncol 1993; 19: 380–7PubMed
18.
Zurück zum Zitat Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and post-inflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 1994; 20: 592–7PubMed Taylor CR, Anderson RR. Ineffective treatment of refractory melasma and post-inflammatory hyperpigmentation by Q-switched ruby laser. J Dermatol Surg Oncol 1994; 20: 592–7PubMed
19.
Zurück zum Zitat Negishi K, Kushikata N, Tezuka Y, et al. Study of the incidence and nature of “very subtle epidermal melasma” in relation to intense pulsed light treatment. Dermatol Surg 2004; 30: 881–6PubMedCrossRef Negishi K, Kushikata N, Tezuka Y, et al. Study of the incidence and nature of “very subtle epidermal melasma” in relation to intense pulsed light treatment. Dermatol Surg 2004; 30: 881–6PubMedCrossRef
20.
Zurück zum Zitat Wang CC, Hui CY, Sue YM, et al. Intense pulsed light for the treatment of refractory melasma in Asian patients. Dermatol Surg 2004; 30: 1196–200PubMedCrossRef Wang CC, Hui CY, Sue YM, et al. Intense pulsed light for the treatment of refractory melasma in Asian patients. Dermatol Surg 2004; 30: 1196–200PubMedCrossRef
21.
Zurück zum Zitat Sanchez NP, Pathak MA, Sato S, et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698–710PubMedCrossRef Sanchez NP, Pathak MA, Sato S, et al. Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol 1981; 4: 698–710PubMedCrossRef
22.
Zurück zum Zitat Griffiths CEM, Finkel LJ, Ditre CM, et al. Topical tretinoin (retinoic acid) improves melasma: a vehicle-controlled, clinical trial. Br J Dermatol 1993; 129: 415–21PubMedCrossRef Griffiths CEM, Finkel LJ, Ditre CM, et al. Topical tretinoin (retinoic acid) improves melasma: a vehicle-controlled, clinical trial. Br J Dermatol 1993; 129: 415–21PubMedCrossRef
23.
Zurück zum Zitat Sarkar R, Kaur C, Bhalla M, et al. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg 2002; 28: 828–32PubMedCrossRef Sarkar R, Kaur C, Bhalla M, et al. The combination of glycolic acid peels with a topical regimen in the treatment of melasma in dark-skinned patients: a comparative study. Dermatol Surg 2002; 28: 828–32PubMedCrossRef
24.
Zurück zum Zitat Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 1999; 25: 18–22PubMedCrossRef Grimes PE. The safety and efficacy of salicylic acid chemical peels in darker racial-ethnic groups. Dermatol Surg 1999; 25: 18–22PubMedCrossRef
25.
Zurück zum Zitat Yoshimura K, Harii K, Aoyama T, et al. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals. Plast Reconstr Surg 2000; 105: 1097–8PubMedCrossRef Yoshimura K, Harii K, Aoyama T, et al. Experience with a strong bleaching treatment for skin hyperpigmentation in Orientals. Plast Reconstr Surg 2000; 105: 1097–8PubMedCrossRef
26.
Zurück zum Zitat Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg 1999; 25: 121–3PubMedCrossRef Manaloto RM, Alster T. Erbium:YAG laser resurfacing for refractory melasma. Dermatol Surg 1999; 25: 121–3PubMedCrossRef
27.
Zurück zum Zitat Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol Surg 2003; 29: 59–64PubMedCrossRef Angsuwarangsee S, Polnikorn N. Combined ultrapulse CO2 laser and Q-switched alexandrite laser compared with Q-switched alexandrite laser alone for refractory melasma: split-face design. Dermatol Surg 2003; 29: 59–64PubMedCrossRef
28.
Zurück zum Zitat Nouri K, Bowes L, Chartier T, et al. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg 1999; 25: 494–7PubMedCrossRef Nouri K, Bowes L, Chartier T, et al. Combination treatment of melasma with pulsed CO2 laser followed by Q-switched alexandrite laser: a pilot study. Dermatol Surg 1999; 25: 494–7PubMedCrossRef
29.
Zurück zum Zitat Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 2005; 31: 1645–50PubMedCrossRef Rokhsar CK, Fitzpatrick RE. The treatment of melasma with fractional photothermolysis: a pilot study. Dermatol Surg 2005; 31: 1645–50PubMedCrossRef
30.
Zurück zum Zitat Wang CC, Sue YM, Yang CH, et al. A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: a randomised, physician-blinded, splitface comparative trial. J Am Acad Dermatol 2006; 54: 804–10PubMedCrossRef Wang CC, Sue YM, Yang CH, et al. A comparison of Q-switched alexandrite laser and intense pulsed light for the treatment of freckles and lentigines in Asian persons: a randomised, physician-blinded, splitface comparative trial. J Am Acad Dermatol 2006; 54: 804–10PubMedCrossRef
31.
Zurück zum Zitat Anderson RR, Margolis RJ, Watenabe S. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532 and 355 nm. J Invest Dermatol 1989; 93: 28–32PubMedCrossRef Anderson RR, Margolis RJ, Watenabe S. Selective photothermolysis of cutaneous pigmentation by Q-switched Nd:YAG laser pulses at 1064, 532 and 355 nm. J Invest Dermatol 1989; 93: 28–32PubMedCrossRef
32.
Zurück zum Zitat Murphy MJ, Huang MY. Q-switched ruby laser treatment of benign pigmented lesions in Chinese skin. Am Acad Med Singapore 1994; 23: 60–6 Murphy MJ, Huang MY. Q-switched ruby laser treatment of benign pigmented lesions in Chinese skin. Am Acad Med Singapore 1994; 23: 60–6
33.
Zurück zum Zitat Chan HH, Fung WKK, Ying SY, et al. An in vivo trial comparing the use of different types of 532 nm Nd:YAG lasers in the treatment of facial lentigines in oriental patients. Derm Surg 2000; 26 (8): 743–9CrossRef Chan HH, Fung WKK, Ying SY, et al. An in vivo trial comparing the use of different types of 532 nm Nd:YAG lasers in the treatment of facial lentigines in oriental patients. Derm Surg 2000; 26 (8): 743–9CrossRef
34.
Zurück zum Zitat Ara G, Anderson RR, Mandel KG, et al. Irradiation of pigmented melanoma cells with high intensity pulsed radiation generates acoustic waves and kill cells. Lasers Surg Med 1990; 10: 52–9PubMedCrossRef Ara G, Anderson RR, Mandel KG, et al. Irradiation of pigmented melanoma cells with high intensity pulsed radiation generates acoustic waves and kill cells. Lasers Surg Med 1990; 10: 52–9PubMedCrossRef
35.
Zurück zum Zitat Negishi K, Tezuka Y, Kushikata N, et al. Photorejuvenation for Asian skin by intense pulsed light. Dermatol Surg 2001; 27: 627–32PubMedCrossRef Negishi K, Tezuka Y, Kushikata N, et al. Photorejuvenation for Asian skin by intense pulsed light. Dermatol Surg 2001; 27: 627–32PubMedCrossRef
36.
Zurück zum Zitat Chan HH. The use of lasers and intense pulsed light sources for the treatment of acquired pigmentary lesions in Asians. J Cosmet Laser Ther 2003; 5: 198–200PubMedCrossRef Chan HH. The use of lasers and intense pulsed light sources for the treatment of acquired pigmentary lesions in Asians. J Cosmet Laser Ther 2003; 5: 198–200PubMedCrossRef
37.
Zurück zum Zitat Negishi K, Wakamatsu S, Kushikata N, et al. Full-face photorejuvenation of photodamaged skin by intense pulsed light with integrated contact cooling: initial experiences in Asian patients. Lasers Surg Med 2002; 30: 298–305PubMedCrossRef Negishi K, Wakamatsu S, Kushikata N, et al. Full-face photorejuvenation of photodamaged skin by intense pulsed light with integrated contact cooling: initial experiences in Asian patients. Lasers Surg Med 2002; 30: 298–305PubMedCrossRef
38.
Zurück zum Zitat Kawada A, Shiraishi H, Asai M, et al. Clinical improvement of solar lentigines and ephelides with an intense pulsed light source. Dermatol Surg 2002; 28: 504–8PubMedCrossRef Kawada A, Shiraishi H, Asai M, et al. Clinical improvement of solar lentigines and ephelides with an intense pulsed light source. Dermatol Surg 2002; 28: 504–8PubMedCrossRef
39.
Zurück zum Zitat Kono T, Manstein D, Chan HH, et al. Q-switched ruby vs. long-pulsed dye laser delivered with compression for treatment of facial lentigines in Asians. Lasers Surg Med 2006; 38: 94–7PubMedCrossRef Kono T, Manstein D, Chan HH, et al. Q-switched ruby vs. long-pulsed dye laser delivered with compression for treatment of facial lentigines in Asians. Lasers Surg Med 2006; 38: 94–7PubMedCrossRef
40.
Zurück zum Zitat Hidano A, Kajama H, Ikeda S, et al. Natural history of nevus of Ota. Arch Dermatol 1967; 95: 187–95PubMedCrossRef Hidano A, Kajama H, Ikeda S, et al. Natural history of nevus of Ota. Arch Dermatol 1967; 95: 187–95PubMedCrossRef
41.
Zurück zum Zitat Chan HH, Alam M, Kono T, et al. Clinical application of lasers in Asians. Dermatol Surg 2002; 28: 556–63PubMedCrossRef Chan HH, Alam M, Kono T, et al. Clinical application of lasers in Asians. Dermatol Surg 2002; 28: 556–63PubMedCrossRef
42.
Zurück zum Zitat Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched ruby laser. New Engl J Med 1994; 331: 1745–50PubMedCrossRef Watanabe S, Takahashi H. Treatment of nevus of Ota with the Q-switched ruby laser. New Engl J Med 1994; 331: 1745–50PubMedCrossRef
43.
Zurück zum Zitat Kono T, Nozaki M, Chan HH, et al. A retrospective study looking at the long-term complications of Q-switched ruby laser in the treatment of nevus of Ota. Lasers Surg Med 2001; 29: 156–9PubMedCrossRef Kono T, Nozaki M, Chan HH, et al. A retrospective study looking at the long-term complications of Q-switched ruby laser in the treatment of nevus of Ota. Lasers Surg Med 2001; 29: 156–9PubMedCrossRef
44.
Zurück zum Zitat Chan HH, King WWK, Chan ESY, et al. An in vivo trial comparing the patients’ tolerability of Q-switched alexandrite and Q-switched neodymium:yttrium-aluminium-garnet lasers in the treatment of nevus of Ota. Lasers Surg Med 1999; 24: 24–8PubMedCrossRef Chan HH, King WWK, Chan ESY, et al. An in vivo trial comparing the patients’ tolerability of Q-switched alexandrite and Q-switched neodymium:yttrium-aluminium-garnet lasers in the treatment of nevus of Ota. Lasers Surg Med 1999; 24: 24–8PubMedCrossRef
45.
Zurück zum Zitat Chan HH, Ying SY, Ho WS, et al. An in vivo trial comparing the clinical efficacy and complications of Q-switched 755nm alexandrite and Q-switched 1064 nm Nd:YAG lasers in the treatment of nevus of Ota. Dermatol Surg 2000; 26: 919–22PubMedCrossRef Chan HH, Ying SY, Ho WS, et al. An in vivo trial comparing the clinical efficacy and complications of Q-switched 755nm alexandrite and Q-switched 1064 nm Nd:YAG lasers in the treatment of nevus of Ota. Dermatol Surg 2000; 26: 919–22PubMedCrossRef
46.
Zurück zum Zitat Hori Y, Kawashima M, Oohara K, et al. Acquired, bilateral nevus of Ota-like macules. J Am Acad Dermatol 1984; 10: 961–4PubMedCrossRef Hori Y, Kawashima M, Oohara K, et al. Acquired, bilateral nevus of Ota-like macules. J Am Acad Dermatol 1984; 10: 961–4PubMedCrossRef
47.
Zurück zum Zitat Hori Y, Takayama O. Circumscribed dermal melanoses: classification and histologic features. Dermatol Clin 1988; 6: 315–26PubMed Hori Y, Takayama O. Circumscribed dermal melanoses: classification and histologic features. Dermatol Clin 1988; 6: 315–26PubMed
48.
Zurück zum Zitat Kunachak S, Leelaudomlipi P, Sirikulchayanonta V. Q-switched ruby laser therapy of acquired bilateral nevus of Ota-like macules. Dermatol Surg 1999; 25: 938–41PubMedCrossRef Kunachak S, Leelaudomlipi P, Sirikulchayanonta V. Q-switched ruby laser therapy of acquired bilateral nevus of Ota-like macules. Dermatol Surg 1999; 25: 938–41PubMedCrossRef
49.
Zurück zum Zitat Lam AY, Wong DS, Lam LK, et al. A retrospective study on the efficacy and complications of Q-switched alexandrite laser in the treatment of acquired bilateral nevus of Ota-like macules. Dermatol Surg 2001; 27: 937–41PubMedCrossRef Lam AY, Wong DS, Lam LK, et al. A retrospective study on the efficacy and complications of Q-switched alexandrite laser in the treatment of acquired bilateral nevus of Ota-like macules. Dermatol Surg 2001; 27: 937–41PubMedCrossRef
50.
Zurück zum Zitat Polnikorn N, Tanrattanakorn S, Goldberg DJ. Treatment of Hori’s nevus with the Q-switched Nd:YAG laser. Dermatol Surg 2000; 26: 477–80PubMedCrossRef Polnikorn N, Tanrattanakorn S, Goldberg DJ. Treatment of Hori’s nevus with the Q-switched Nd:YAG laser. Dermatol Surg 2000; 26: 477–80PubMedCrossRef
51.
Zurück zum Zitat Ee HL, Goh CL, Khoo LS, et al. Treatment of acquired bilateral nevus of Ota-like macules (Hori’s nevus) with a combination of the 532 nm Q-switched Nd:YAG followed by the 1064 nm Q-switched Nd:YAG is more effective: prospective study. Dermatol Surg 2006; 32: 34–40PubMed Ee HL, Goh CL, Khoo LS, et al. Treatment of acquired bilateral nevus of Ota-like macules (Hori’s nevus) with a combination of the 532 nm Q-switched Nd:YAG followed by the 1064 nm Q-switched Nd:YAG is more effective: prospective study. Dermatol Surg 2006; 32: 34–40PubMed
52.
Zurück zum Zitat Hse TS, Zelickson B, Dover JS, et al. Multicenter study of the safety and efficacy of a 585nm pulsed-dye laser for the nonablative treatment of facial rhytides. Dermatol Surg 2005; 31: 1–9 Hse TS, Zelickson B, Dover JS, et al. Multicenter study of the safety and efficacy of a 585nm pulsed-dye laser for the nonablative treatment of facial rhytides. Dermatol Surg 2005; 31: 1–9
53.
Zurück zum Zitat Trelles MA, Allones I, Levy JL, et al. Combined nonablative skin rejuvenation with the 595- and 1450-nm lasers. Dermatol Surg 2004; 30: 1292–8PubMedCrossRef Trelles MA, Allones I, Levy JL, et al. Combined nonablative skin rejuvenation with the 595- and 1450-nm lasers. Dermatol Surg 2004; 30: 1292–8PubMedCrossRef
54.
Zurück zum Zitat Fitzpatrick R, Geronemus RG, Goldberg D, et al. Multicenter study of noninvasive radiofrequency for periorbital tissue tightening. Lasers Surg Med 2003; 33: 232–42PubMedCrossRef Fitzpatrick R, Geronemus RG, Goldberg D, et al. Multicenter study of noninvasive radiofrequency for periorbital tissue tightening. Lasers Surg Med 2003; 33: 232–42PubMedCrossRef
55.
Zurück zum Zitat Kushikata N, Negishi K, Tezuka Y, et al. Non-ablative skin tightening with radiofrequency in Asian skin. Lasers Surg Med 2005; 36: 92–7PubMedCrossRef Kushikata N, Negishi K, Tezuka Y, et al. Non-ablative skin tightening with radiofrequency in Asian skin. Lasers Surg Med 2005; 36: 92–7PubMedCrossRef
56.
Zurück zum Zitat Dover JS, Zelickson B, 14-Physician Multispecialty Consensus Panel. Results of a survey of 5,700 patient monopolar radiofrequency facial skin tightening treatments: assessment of a low-energy multiple-pass technique leading to a clinical end point algorithm. Derm Surg 2007 May; 33 (8): 900–7 Dover JS, Zelickson B, 14-Physician Multispecialty Consensus Panel. Results of a survey of 5,700 patient monopolar radiofrequency facial skin tightening treatments: assessment of a low-energy multiple-pass technique leading to a clinical end point algorithm. Derm Surg 2007 May; 33 (8): 900–7
57.
Zurück zum Zitat Chua-Ty G, Goh CL, Koh SL. Pattern of skin diseases at the National Skin Centre (Singapore) from 1989-1990. Int J Dermatol 1992; 31: 555–9PubMedCrossRef Chua-Ty G, Goh CL, Koh SL. Pattern of skin diseases at the National Skin Centre (Singapore) from 1989-1990. Int J Dermatol 1992; 31: 555–9PubMedCrossRef
58.
Zurück zum Zitat Mar A, Tam A, Jolley D, et al. The cumulative incidence of atopic dermatitis in the first 12 months among Chinese, Vietnamese, and Caucasian infants born in Melbourne, Australia. J Am Acad Dermatol 1999; 40: 597–602PubMedCrossRef Mar A, Tam A, Jolley D, et al. The cumulative incidence of atopic dermatitis in the first 12 months among Chinese, Vietnamese, and Caucasian infants born in Melbourne, Australia. J Am Acad Dermatol 1999; 40: 597–602PubMedCrossRef
59.
Zurück zum Zitat Worth R. Atopic dermatitis among Chinese infants in Honolulu and San Francisco. Hawaii Med J 1962; 22: 31–4 Worth R. Atopic dermatitis among Chinese infants in Honolulu and San Francisco. Hawaii Med J 1962; 22: 31–4
60.
Zurück zum Zitat George S, Berth-Jones J, Graham-Brown R. A possible explanation for the increased referral of atopic dermatitis from the Asian community in Leicester. Br J Dermatol 1997; 136: 494–7PubMedCrossRef George S, Berth-Jones J, Graham-Brown R. A possible explanation for the increased referral of atopic dermatitis from the Asian community in Leicester. Br J Dermatol 1997; 136: 494–7PubMedCrossRef
61.
Zurück zum Zitat Levy ML. Atopic dermatitis: understanding the disease and its management. Curr Med Res Opin 2007 Dec; 23 (12): 3091–103PubMedCrossRef Levy ML. Atopic dermatitis: understanding the disease and its management. Curr Med Res Opin 2007 Dec; 23 (12): 3091–103PubMedCrossRef
62.
Zurück zum Zitat Yeung CK, Teo LHY, Xiang LH, et al. A community-based epidemiological study of acne vulgaris in Hong Kong adolescents. Acta Derm Venereol 2002; 82: 104–7PubMedCrossRef Yeung CK, Teo LHY, Xiang LH, et al. A community-based epidemiological study of acne vulgaris in Hong Kong adolescents. Acta Derm Venereol 2002; 82: 104–7PubMedCrossRef
63.
Zurück zum Zitat Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol 2002; 46 (2 Suppl.): S98–106CrossRef Taylor SC, Cook-Bolden F, Rahman Z, et al. Acne vulgaris in skin of color. J Am Acad Dermatol 2002; 46 (2 Suppl.): S98–106CrossRef
64.
Zurück zum Zitat Jeong JT, Park JH, Kye YC. Resurfacing of pitted facial acne scars using Er:YAG laser with ablation and coagulation mode. Aesthetic Plast Surg 2003; 27: 130–4PubMedCrossRef Jeong JT, Park JH, Kye YC. Resurfacing of pitted facial acne scars using Er:YAG laser with ablation and coagulation mode. Aesthetic Plast Surg 2003; 27: 130–4PubMedCrossRef
65.
Zurück zum Zitat Wala S, Alster TS. Prolonged clinical and histological effects from CO2 laser resurfacing of atrophic acne scars. Dermatol Surg 1999; 25: 926–30CrossRef Wala S, Alster TS. Prolonged clinical and histological effects from CO2 laser resurfacing of atrophic acne scars. Dermatol Surg 1999; 25: 926–30CrossRef
66.
Zurück zum Zitat Goh CL, Khoo L. Laser skin resurfacing treatment outcome of facial scars and wrinkles in Asians with skin type III/IV with the Unipulse CO2 laser system. Singapore Med J 2002; 43: 28–32PubMed Goh CL, Khoo L. Laser skin resurfacing treatment outcome of facial scars and wrinkles in Asians with skin type III/IV with the Unipulse CO2 laser system. Singapore Med J 2002; 43: 28–32PubMed
67.
Zurück zum Zitat Ashkenazi H, Malik Z, Harth Y, et al. Eradication of Proprionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol 2003; 35: 17–24PubMedCrossRef Ashkenazi H, Malik Z, Harth Y, et al. Eradication of Proprionibacterium acnes by its endogenic porphyrins after illumination with high intensity blue light. FEMS Immunol Med Microbiol 2003; 35: 17–24PubMedCrossRef
68.
Zurück zum Zitat Seaton ED, Charakida A, Mouser PE, et al. Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial. Lancet 2003; 362: 1347–52PubMedCrossRef Seaton ED, Charakida A, Mouser PE, et al. Pulsed-dye laser treatment for inflammatory acne vulgaris: randomised controlled trial. Lancet 2003; 362: 1347–52PubMedCrossRef
69.
Zurück zum Zitat Orringer JS, Kang S, Hamilton T, et al. Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial. JAMA 2004; 291 (23): 2834–9PubMedCrossRef Orringer JS, Kang S, Hamilton T, et al. Treatment of acne vulgaris with a pulsed dye laser: a randomized controlled trial. JAMA 2004; 291 (23): 2834–9PubMedCrossRef
70.
Zurück zum Zitat Goldman MP, Boyce SM. A single-center study of aminolevulinic acid and 417nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J Drugs Dermatol 2003; 2: 393–6PubMed Goldman MP, Boyce SM. A single-center study of aminolevulinic acid and 417nm photodynamic therapy in the treatment of moderate to severe acne vulgaris. J Drugs Dermatol 2003; 2: 393–6PubMed
71.
Zurück zum Zitat Alexiades-Armenakas M. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne. J Drugs Dermatol 2006; 5: 45–55PubMed Alexiades-Armenakas M. Long-pulsed dye laser-mediated photodynamic therapy combined with topical therapy for mild to severe comedonal, inflammatory, or cystic acne. J Drugs Dermatol 2006; 5: 45–55PubMed
72.
Zurück zum Zitat Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000 Aug; 115 (2): 183–92PubMedCrossRef Hongcharu W, Taylor CR, Chang Y, et al. Topical ALA-photodynamic therapy for the treatment of acne vulgaris. J Invest Dermatol 2000 Aug; 115 (2): 183–92PubMedCrossRef
73.
Zurück zum Zitat Chua SH, Ang P, Khoo LSW, et al. Nonablative 1450 nm diode laser in the treatment of facial atrophic acne scars in type IV to V Asian skin: a prospective clinical study. Dermatol Surg 2004; 30 (10): 1287–91PubMedCrossRef Chua SH, Ang P, Khoo LSW, et al. Nonablative 1450 nm diode laser in the treatment of facial atrophic acne scars in type IV to V Asian skin: a prospective clinical study. Dermatol Surg 2004; 30 (10): 1287–91PubMedCrossRef
74.
Zurück zum Zitat Bernstein EF. A pilot investigation comparing low-energy, double pass 1,450nm laser treatment of acne to conventional single-pass, high-energy treatment. Lasers Surg Med 2007; 39 (2): 193–8PubMedCrossRef Bernstein EF. A pilot investigation comparing low-energy, double pass 1,450nm laser treatment of acne to conventional single-pass, high-energy treatment. Lasers Surg Med 2007; 39 (2): 193–8PubMedCrossRef
75.
Zurück zum Zitat Kono T, Chan HHL, Groff WF, et al. Prospective direct comparison study of fractional resurfacing using different fluences and densities for skin rejuvenation in Asians. Lasers Surg Med 2007; 39 (4): 311–4PubMedCrossRef Kono T, Chan HHL, Groff WF, et al. Prospective direct comparison study of fractional resurfacing using different fluences and densities for skin rejuvenation in Asians. Lasers Surg Med 2007; 39 (4): 311–4PubMedCrossRef
76.
Zurück zum Zitat Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002; 46 (2 Suppl.): S63–97CrossRef Shaffer JJ, Taylor SC, Cook-Bolden F. Keloidal scars: a review with a critical look at therapeutic options. J Am Acad Dermatol 2002; 46 (2 Suppl.): S63–97CrossRef
77.
Zurück zum Zitat Reed BR, Clark RA. Cutaneous tissue repair: practical implications of current knowledge: II. J Am Acad Dermatol 1985; 13: 919–41PubMedCrossRef Reed BR, Clark RA. Cutaneous tissue repair: practical implications of current knowledge: II. J Am Acad Dermatol 1985; 13: 919–41PubMedCrossRef
78.
Zurück zum Zitat Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids: a collective review. Plast Reconstr Surg 1974; 53: 140–54PubMedCrossRef Ketchum LD, Cohen IK, Masters FW. Hypertrophic scars and keloids: a collective review. Plast Reconstr Surg 1974; 53: 140–54PubMedCrossRef
79.
Zurück zum Zitat Friedman SJ, Butler DR, Dittelkov MR. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. J Am Acad Dermatol 1988; 19: 537–41PubMedCrossRef Friedman SJ, Butler DR, Dittelkov MR. Perilesional linear atrophy and hypopigmentation after intralesional corticosteroid therapy. J Am Acad Dermatol 1988; 19: 537–41PubMedCrossRef
80.
Zurück zum Zitat Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999; 25: 224–32PubMedCrossRef Fitzpatrick RE. Treatment of inflamed hypertrophic scars using intralesional 5-FU. Dermatol Surg 1999; 25: 224–32PubMedCrossRef
81.
Zurück zum Zitat Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg 1995; 21: 685–7PubMed Goldman MP, Fitzpatrick RE. Laser treatment of scars. Dermatol Surg 1995; 21: 685–7PubMed
82.
Zurück zum Zitat Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet 1995; 345: 1198–200PubMedCrossRef Alster TS, Williams CM. Treatment of keloid sternotomy scars with 585 nm flashlamp-pumped pulsed-dye laser. Lancet 1995; 345: 1198–200PubMedCrossRef
83.
Zurück zum Zitat Manuskiatti W, Fitzpatrick RE, Goldman MP. Energy density and numbers of treatment affect response of keloidal and hypertrophic scars to the 585-nm flashlamp-pumped pulsed-dye laser. J Am Acad Dermatol 2001; 45 (4): 557–65PubMedCrossRef Manuskiatti W, Fitzpatrick RE, Goldman MP. Energy density and numbers of treatment affect response of keloidal and hypertrophic scars to the 585-nm flashlamp-pumped pulsed-dye laser. J Am Acad Dermatol 2001; 45 (4): 557–65PubMedCrossRef
84.
Zurück zum Zitat Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 2002; 138 (9): 1149–55PubMedCrossRef Manuskiatti W, Fitzpatrick RE. Treatment response of keloidal hypertrophic sternotomy scars: comparison among intralesional corticosteroid, 5-fluorouracil, and 585-nm flashlamp-pumped pulsed-dye laser treatments. Arch Dermatol 2002; 138 (9): 1149–55PubMedCrossRef
85.
Zurück zum Zitat Chan HH, Wong DS, Ho WS, et al. The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in Chinese. Dermatol Surg 2004; 30: 987–94PubMedCrossRef Chan HH, Wong DS, Ho WS, et al. The use of pulsed dye laser for the prevention and treatment of hypertrophic scars in Chinese. Dermatol Surg 2004; 30: 987–94PubMedCrossRef
87.
Zurück zum Zitat Farber E, Grauer F, Zaruba F. Racial incidence of psoriasis. Cesk Dermatol 1965; 40: 289–97PubMed Farber E, Grauer F, Zaruba F. Racial incidence of psoriasis. Cesk Dermatol 1965; 40: 289–97PubMed
88.
Zurück zum Zitat Murase JE, Lee EE, Koo J. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy. Int J Dermatol 2005; 44: 1016–21PubMedCrossRef Murase JE, Lee EE, Koo J. Effect of ethnicity on the risk of developing nonmelanoma skin cancer following long-term PUVA therapy. Int J Dermatol 2005; 44: 1016–21PubMedCrossRef
90.
Zurück zum Zitat Wang WJ, Chang YT, Huang CY, et al. Clinical and histopathological characteristics of primary cutaneous amyloidosis in 794 Chinese patients. Zhonghua Yi Xue Za Zhi (Taipei) 2001; 64 (2): 101–7 Wang WJ, Chang YT, Huang CY, et al. Clinical and histopathological characteristics of primary cutaneous amyloidosis in 794 Chinese patients. Zhonghua Yi Xue Za Zhi (Taipei) 2001; 64 (2): 101–7
92.
Zurück zum Zitat Wang W, Huang C, Chang Y, et al. Anosacral cutaneous amyloidosis: a study of 10 Chinese cases. Br J Dermatol 2000; 143: 1266–9PubMedCrossRef Wang W, Huang C, Chang Y, et al. Anosacral cutaneous amyloidosis: a study of 10 Chinese cases. Br J Dermatol 2000; 143: 1266–9PubMedCrossRef
94.
Zurück zum Zitat Juan CC, Hwang B, Lee PC, et al. The clinical manifestations and risk factors of a delayed diagnosis of Kawasaki disease. J Chin Med Assoc 2007; 70 (9): 374–9PubMedCrossRef Juan CC, Hwang B, Lee PC, et al. The clinical manifestations and risk factors of a delayed diagnosis of Kawasaki disease. J Chin Med Assoc 2007; 70 (9): 374–9PubMedCrossRef
95.
Zurück zum Zitat Dean A, Melish M, Hicks R, et al. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr 1982; 100: 552–7PubMedCrossRef Dean A, Melish M, Hicks R, et al. An epidemic of Kawasaki syndrome in Hawaii. J Pediatr 1982; 100: 552–7PubMedCrossRef
96.
97.
Zurück zum Zitat Jemal A, Devesa SS, Hartge P, et al. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001; 93: 678–83PubMedCrossRef Jemal A, Devesa SS, Hartge P, et al. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst 2001; 93: 678–83PubMedCrossRef
98.
Zurück zum Zitat Koh D, Wang H, Lee J, et al. Basal cell carcinoma, squamous cell carcinoma andmelanoma of the skin: analysis of the Singapore Cancer Registry Data 1968-1997. Br J Dermatol 2003; 148: 1161–6PubMedCrossRef Koh D, Wang H, Lee J, et al. Basal cell carcinoma, squamous cell carcinoma andmelanoma of the skin: analysis of the Singapore Cancer Registry Data 1968-1997. Br J Dermatol 2003; 148: 1161–6PubMedCrossRef
99.
Zurück zum Zitat Waterhouse J, Correa P, Muir C, et al., editors. Cancer incidence in five continents: vol. 4. Lyon: International Agency for Research in Cancer, 1976 Waterhouse J, Correa P, Muir C, et al., editors. Cancer incidence in five continents: vol. 4. Lyon: International Agency for Research in Cancer, 1976
100.
Zurück zum Zitat Ishihara K, Saida T, Yamamoto A. Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 2001; 6: 109–16PubMedCrossRef Ishihara K, Saida T, Yamamoto A. Updated statistical data for malignant melanoma in Japan. Int J Clin Oncol 2001; 6: 109–16PubMedCrossRef
101.
Zurück zum Zitat Collins RJ. Melanoma in the Chinese of HongKong: emphasis on volar and subungual sites. Cancer 1984; 54: 1482–8PubMedCrossRef Collins RJ. Melanoma in the Chinese of HongKong: emphasis on volar and subungual sites. Cancer 1984; 54: 1482–8PubMedCrossRef
102.
Zurück zum Zitat Byrd KM, Wilson DC, Hoyler SS. Advanced presentation of melanoma in African Americans. J Am Acad Dermatol 2004; 50: 142–3CrossRef Byrd KM, Wilson DC, Hoyler SS. Advanced presentation of melanoma in African Americans. J Am Acad Dermatol 2004; 50: 142–3CrossRef
103.
Zurück zum Zitat Kikuchi A, Shimizu H, Nishikawa T. Clinical and histopathological characteristics of basal cell carcinoma in Japanese patients. Arch Dermatol 1996; 132: 320–4PubMedCrossRef Kikuchi A, Shimizu H, Nishikawa T. Clinical and histopathological characteristics of basal cell carcinoma in Japanese patients. Arch Dermatol 1996; 132: 320–4PubMedCrossRef
104.
Zurück zum Zitat Chuang T, Reizner GT, Elpern DJ, et al. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report. J Am Acad Dermatol 1995; 33: 422–6PubMedCrossRef Chuang T, Reizner GT, Elpern DJ, et al. Nonmelanoma skin cancer in Japanese ethnic Hawaiians in Kauai, Hawaii: an incidence report. J Am Acad Dermatol 1995; 33: 422–6PubMedCrossRef
105.
Zurück zum Zitat Ichihashi M, Naruse K, Harada S, et al. Trends in nonmelanoma skin cancer in Japan. Recent Results Cancer Res 1995; 139: 263–73PubMedCrossRef Ichihashi M, Naruse K, Harada S, et al. Trends in nonmelanoma skin cancer in Japan. Recent Results Cancer Res 1995; 139: 263–73PubMedCrossRef
106.
107.
Zurück zum Zitat Stone MC, Styles AR, Cockerell CJ. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis 2001; 67: 133–8PubMed Stone MC, Styles AR, Cockerell CJ. Hypopigmented mycosis fungoides: a report of 7 cases and review of the literature. Cutis 2001; 67: 133–8PubMed
108.
Zurück zum Zitat Lambroza E, Cohen SR, Phelps R, et al. Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases. J Am Acad Dermatol 1995; 32: 987–93PubMedCrossRef Lambroza E, Cohen SR, Phelps R, et al. Hypopigmented variant of mycosis fungoides: demography, histopathology, and treatment of seven cases. J Am Acad Dermatol 1995; 32: 987–93PubMedCrossRef
109.
Zurück zum Zitat Akaraphanth R, Douglass MC, Lim HW. Hypopigmented mycosis fungoides: treatment and a 6(1/2) year follow-up of 9 patients. J Am Acad Dermatol 2000; 42: 33–9PubMedCrossRef Akaraphanth R, Douglass MC, Lim HW. Hypopigmented mycosis fungoides: treatment and a 6(1/2) year follow-up of 9 patients. J Am Acad Dermatol 2000; 42: 33–9PubMedCrossRef
110.
Zurück zum Zitat Blitzer A, Brin MF, Keen MS, et al. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993; 119 (9): 1018–22PubMedCrossRef Blitzer A, Brin MF, Keen MS, et al. Botulinum toxin for the treatment of hyperfunctional lines of the face. Arch Otolaryngol Head Neck Surg 1993; 119 (9): 1018–22PubMedCrossRef
111.
Zurück zum Zitat Anh KY, Park MY, Park DH, et al. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. Plast Reconstr Surg 2000; 105 (2): 778–84CrossRef Anh KY, Park MY, Park DH, et al. Botulinum toxin A for the treatment of facial hyperkinetic wrinkle lines in Koreans. Plast Reconstr Surg 2000; 105 (2): 778–84CrossRef
112.
Zurück zum Zitat Carruthers A, Carruthers JDA. The use of botulinum toxin to treat glabellar frown lines and other facial wrinkles. Cosmet Dermatol 1997; 7: 11–5 Carruthers A, Carruthers JDA. The use of botulinum toxin to treat glabellar frown lines and other facial wrinkles. Cosmet Dermatol 1997; 7: 11–5
113.
Zurück zum Zitat Flynn TC, Carruthers JA, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 2001; 27 (8): 703–8PubMedCrossRef Flynn TC, Carruthers JA, Carruthers JA. Botulinum-A toxin treatment of the lower eyelid improves infraorbital rhytides and widens the eye. Dermatol Surg 2001; 27 (8): 703–8PubMedCrossRef
114.
Zurück zum Zitat Kim NH, Chung JH, Park RH, et al. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 2005; 115 (3): 919–30PubMedCrossRef Kim NH, Chung JH, Park RH, et al. The use of botulinum toxin type A in aesthetic mandibular contouring. Plast Reconstr Surg 2005; 115 (3): 919–30PubMedCrossRef
115.
Zurück zum Zitat Lee HJ, Lee DW, Park YH, et al. Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscle. Dermatol Surg 2004; 30 (6): 867–71PubMedCrossRef Lee HJ, Lee DW, Park YH, et al. Botulinum toxin A for aesthetic contouring of enlarged medial gastrocnemius muscle. Dermatol Surg 2004; 30 (6): 867–71PubMedCrossRef
116.
Zurück zum Zitat Han KH, Joo YH, Moon SE, et al. Botulinum toxin A treatment for contouring of the lower leg. J Dermatolog Treat 2006; 17 (4): 250–4PubMedCrossRef Han KH, Joo YH, Moon SE, et al. Botulinum toxin A treatment for contouring of the lower leg. J Dermatolog Treat 2006; 17 (4): 250–4PubMedCrossRef
117.
Zurück zum Zitat Klein AW. In favour of double testing. J Dermatol Surg Oncol 1989; 15: 263PubMed Klein AW. In favour of double testing. J Dermatol Surg Oncol 1989; 15: 263PubMed
118.
Zurück zum Zitat Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29: 588–95PubMedCrossRef Narins RS, Brandt F, Leyden J, et al. A randomized, double-blind, multicenter comparison of the efficacy and tolerability of Restylane versus Zyplast for the correction of nasolabial folds. Dermatol Surg 2003; 29: 588–95PubMedCrossRef
119.
Zurück zum Zitat Lowe NJ, Maxwell A, Lowe P, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol 2001; 45: 930–3PubMedCrossRef Lowe NJ, Maxwell A, Lowe P, et al. Hyaluronic acid skin fillers: adverse reactions and skin testing. J Am Acad Dermatol 2001; 45: 930–3PubMedCrossRef
120.
Zurück zum Zitat Vartanian AJ, Frankel AS, Rubin MG. Injected hyaluronidase reduces Restylane-mediated cutaneous augmentation. Arch Fac Plast Surg 2005; 7: 231–7CrossRef Vartanian AJ, Frankel AS, Rubin MG. Injected hyaluronidase reduces Restylane-mediated cutaneous augmentation. Arch Fac Plast Surg 2005; 7: 231–7CrossRef
121.
Zurück zum Zitat Cohen SR, Holmes RE. Artecoll: a long-lasting injectable wrinkle filler material. Report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 2004; 114 (4): 964–76 Cohen SR, Holmes RE. Artecoll: a long-lasting injectable wrinkle filler material. Report of a controlled, randomized, multicenter clinical trial of 251 subjects. Plast Reconstr Surg 2004; 114 (4): 964–76
122.
Zurück zum Zitat Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003; 29: 573–87PubMedCrossRef Lemperle G, Romano JJ, Busso M. Soft tissue augmentation with Artecoll: 10-year history, indications, techniques, and complications. Dermatol Surg 2003; 29: 573–87PubMedCrossRef
123.
Zurück zum Zitat Carruthers A, Carruthers JDA. Polymethylmethacrylate microspheres/collagen as a tissue augmenting agent: personal experience over 5 years. Dermatol Surg 2005; 31: 1561–5PubMedCrossRef Carruthers A, Carruthers JDA. Polymethylmethacrylate microspheres/collagen as a tissue augmenting agent: personal experience over 5 years. Dermatol Surg 2005; 31: 1561–5PubMedCrossRef
124.
Zurück zum Zitat Arnaud P, Saint-Marc T, Katz P. The effects of polylactic acid (PLA) [New-Fill] as therapy for lipoatrophy of the face [abstract]. 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV; 2000 Sep 13–15; Toronto (ON) Arnaud P, Saint-Marc T, Katz P. The effects of polylactic acid (PLA) [New-Fill] as therapy for lipoatrophy of the face [abstract]. 2nd International Workshop on Adverse Drug Reactions and Lipodystrophy in HIV; 2000 Sep 13–15; Toronto (ON)
125.
Zurück zum Zitat Beljaards RC, de Roos K, Bruins FG. New-Fill for skin augmentation: a new filler or failure? Dermatol Surg 2005; 31: 772–6PubMedCrossRef Beljaards RC, de Roos K, Bruins FG. New-Fill for skin augmentation: a new filler or failure? Dermatol Surg 2005; 31: 772–6PubMedCrossRef
Metadaten
Titel
The Asian Dermatologic Patient
Review of Common Pigmentary Disorders and Cutaneous Diseases
verfasst von
Stephanie G.Y. Ho
Dr Henry H.L. Chan
Publikationsdatum
01.06.2009
Verlag
Springer International Publishing
Erschienen in
American Journal of Clinical Dermatology / Ausgabe 3/2009
Print ISSN: 1175-0561
Elektronische ISSN: 1179-1888
DOI
https://doi.org/10.2165/00128071-200910030-00002

Weitere Artikel der Ausgabe 3/2009

American Journal of Clinical Dermatology 3/2009 Zur Ausgabe

Leitlinien kompakt für die Dermatologie

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Dermatologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.